Literature DB >> 33985687

Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.

David Marlevi1, Elazer R Edelman2.   

Abstract

Drug delivery is central to modern cardiovascular care, where drug-eluting stents, bioresorbable scaffolds, and drug-coated balloons all aim to restore perfusion while inhibiting exuberant healing. The promise and enthusiasm of these devices has in some cases exceeded demonstration of efficacy and even understanding of driving mechanisms. The authors review the means of drug delivery in each device, outlining how the technologies affect vascular behavior. They focus on how drug retention and response are governed by lesion morphology: lipid displacing drug-specific binding sites, calcium inhibiting diffusion, blocking thrombi or promoting luminal washout, and vascular healing steering hyperplastic developments. In this regard, the authors outline the fundamental impact of vascular structure on drug delivery and review the development of contemporary and future devices for coronary and peripheral intervention. They look toward a future where incorporating information on lesion distribution is central to therapeutic success and envision a transition toward lesion-specific treatment for improved interventional outcomes.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atherosclerosis; drug delivery; endovascular therapy; lesion morphology; lesion-specific treatment

Year:  2021        PMID: 33985687      PMCID: PMC8238531          DOI: 10.1016/j.jacc.2021.03.307

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  97 in total

1.  Stent elution rate determines drug deposition and receptor-mediated effects.

Authors:  Abraham R Tzafriri; Adam Groothuis; G Sylvester Price; Elazer R Edelman
Journal:  J Control Release       Date:  2012-05-26       Impact factor: 9.776

2.  Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.

Authors:  Takeshi Tada; Kazushige Kadota; Shingo Hosogi; Koshi Miyake; Hideo Amano; Michitaka Nakamura; Yu Izawa; Shunsuke Kubo; Tahei Ichinohe; Yusuke Hyoudou; Haruki Eguchi; Yuki Hayakawa; Suguru Otsuru; Daiji Hasegawa; Yoshikazu Shigemoto; Seiji Habara; Hiroyuki Tanaka; Yasushi Fuku; Harumi Kato; Tsuyoshi Goto; Kazuaki Mitsudo
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-09-15       Impact factor: 6.875

3.  Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents.

Authors:  Philippe Généreux; Björn Redfors; Bernhard Witzenbichler; Marie-Pier Arsenault; Giora Weisz; Thomas D Stuckey; Michael J Rinaldi; Franz-Josef Neumann; D Christopher Metzger; Timothy D Henry; David A Cox; Peter L Duffy; Ernest L Mazzaferri; Dominic P Francese; Guillaume Marquis-Gravel; Gary S Mintz; Ajay J Kirtane; Akiko Maehara; Roxana Mehran; Gregg W Stone
Journal:  Int J Cardiol       Date:  2016-12-26       Impact factor: 4.164

4.  A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial.

Authors:  Fernando Alfonso; María Jose Pérez-Vizcayno; Alberto Cárdenas; Bruno García del Blanco; Arturo García-Touchard; José Ramón López-Minguéz; Amparo Benedicto; Mónica Masotti; Javier Zueco; Andrés Iñiguez; Maite Velázquez; Raúl Moreno; Vicente Mainar; Antonio Domínguez; Francisco Pomar; Rafael Melgares; Fernando Rivero; Pilar Jiménez-Quevedo; Nieves Gonzalo; Cristina Fernández; Carlos Macaya
Journal:  J Am Coll Cardiol       Date:  2015-07-07       Impact factor: 24.094

5.  Arterial paclitaxel distribution and deposition.

Authors:  C J Creel; M A Lovich; E R Edelman
Journal:  Circ Res       Date:  2000-04-28       Impact factor: 17.367

6.  Rapamycin inhibits vascular smooth muscle cell migration.

Authors:  M Poon; S O Marx; R Gallo; J J Badimon; M B Taubman; A R Marks
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

7.  Stenting for carotid artery stenosis: fractures, proposed etiology and the need for surveillance.

Authors:  Adrian James Ling; Patrice Mwipatayi; Tarun Gandhi; Kishore Sieunarine
Journal:  J Vasc Surg       Date:  2008-04-28       Impact factor: 4.268

8.  Impact of artificial plaque composition on drug transport.

Authors:  Ji Guo; David M Saylor; Ethan P Glaser; Dinesh V Patwardhan
Journal:  J Pharm Sci       Date:  2013-04-09       Impact factor: 3.534

9.  Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.

Authors:  Antonio Colombo; Janusz Drzewiecki; Adrian Banning; Eberhard Grube; Karl Hauptmann; Sigmund Silber; Dariusz Dudek; Stephen Fort; Francois Schiele; Krysztof Zmudka; Giulio Guagliumi; Mary E Russell
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

10.  Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Konstantinos Katsanos; Stavros Spiliopoulos; Panagiotis Kitrou; Miltiadis Krokidis; Dimitrios Karnabatidis
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

View more
  1 in total

Review 1.  Three Technologies That Will Guide Revascularization of Chronic Coronary Syndrome Patients into the 21st Century: A Review.

Authors:  Michael A Winkler; Ripa Patel; Weibo Fu; Vishal Arora; Neal L Weintraub
Journal:  Int J Angiol       Date:  2021-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.